BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maramai S, Brindisi M. Targeting Endocannabinoid Metabolism: an Arrow with Multiple Tips Against Multiple Sclerosis. ChemMedChem 2020;15:1985-2003. [PMID: 32762071 DOI: 10.1002/cmdc.202000310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sabnis RW. Heterocyclic Compounds as Monoacylglycerol Lipase (MAGL) Inhibitors. ACS Med Chem Lett 2021;12:536-7. [PMID: 33859792 DOI: 10.1021/acsmedchemlett.1c00149] [Reference Citation Analysis]
2 Malamas MS, Lamani M, Farah SI, Mohammad KA, Miyabe CY, Rajarshi G, Wu S, Zvonok N, Chandrashekhar H, Wood J, Makriyannis A. Design and Synthesis of Highly Potent and Specific ABHD6 Inhibitors. ChemMedChem 2021. [PMID: 34486233 DOI: 10.1002/cmdc.202100406] [Reference Citation Analysis]
3 Sabnis RW. Novel Oxazine Monoacylglycerol Lipase (MAGL) Inhibitors. ACS Med Chem Lett 2021;12:312-3. [PMID: 33738048 DOI: 10.1021/acsmedchemlett.1c00055] [Reference Citation Analysis]